Treatment for canine hemangiosarcoma (HSA) of the spleen.

Study details.

Qualified patients in this fully-funded study (all diagnostics, treatment, and exams) will receive 4 doses of Paccal Vet® chemotherapy and will be monitored for up to 12 months following spleen removal.

Inclusion criteria:

Exclusion criteria:

Locations and contacts:

Duration of study.

Patient participation will be up to 12 months. The study will be active until 2026.

Covered costs.

All study-related costs are covered by the sponsor.